Physician profile
Hillary B Loper
NPI 1568698660
$5,439.84
in general payments reported to CMS, 2019-2025
39 companies · $751 in 2025
The $751 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,086 · 2020: $473 · 2021: $516 · 2022: $876 · 2023: $1,001 · 2024: $737 · 2025: $751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,488.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,311.86 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $554.88 | 2019-2023 | Farxiga |
| Lilly USA, LLC | $356.58 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Amgen INC. | $292.03 | 2019-2025 | Prolia, Evenity, Prolia |
| Sanofi-Aventis U.S. LLC | $267.53 | 2019-2025 | |
| Abbvie INC. | $253.35 | 2021-2025 | |
| Abbott Laboratories | $251.34 | 2020-2024 | Freestyle Libre 3 |
| Corcept Therapeutics | $233.20 | 2021-2025 | Korlym |
| Radius Health, INC. | $191.99 | 2019-2025 | Tymlos |
| Amarin Pharma, INC. | $186.77 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $182.98 | 2020-2025 | Gvoke Hypopen |
| Glaxosmithkline, LLC. | $123.87 | 2024 | Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.01 | 2019-2024 | Jardiance, Synjardy, Tradjenta |
| Medtronic, INC. | $109.68 | 2021-2025 | Minimed 780g |
| Inspire Medical Systems, INC. | $101.40 | 2025 | Inspire |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $88.72 | 2019-2024 | Capvaxive |
| Beta Bionics, INC. | $83.91 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Dexcom, INC. | $69.22 | 2023-2024 | Dexcom G6 Transmitter |
| Lifescan, INC. | $67.79 | 2020-2022 | |
| Tandem Diabetes Care, INC. | $62.84 | 2022-2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Janssen Pharmaceuticals, INC | $61.65 | 2019-2020 | |
| Daiichi Sankyo INC. | $53.23 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.88 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $34.81 | 2023 | |
| Insulet Corporation | $34.21 | 2022-2023 | Omnipod |
| Sequel Med Tech, LLC | $33.28 | 2025 | Twiist |
| Kyowa Kirin, INC. | $29.56 | 2024 | Crysvita |
| Mannkind Corporation | $29.45 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $28.95 | 2024 | Gemtesa |
| Becton, Dickinson and Company | $26.65 | 2019 | |
| Grt US Holding, INC. | $24.49 | 2022 | |
| Alnylam Pharmaceuticals INC. | $20.27 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.79 | 2021 | |
| Nevro Corp. | $16.20 | 2024 | Senza |
| Biohaven Pharmaceutical Holding Company LTD. | $15.75 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $14.90 | 2024 | Evkeeza |
| Teva Pharmaceuticals USA, INC. | $13.84 | 2022 | |
| Embecta Corp. | $13.28 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Medtronic Minimed, INC. | $12.70 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hillary Loper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.